FERRERO, Ivana
 Distribuzione geografica
Continente #
NA - Nord America 3.157
EU - Europa 1.687
AS - Asia 932
SA - Sud America 39
AF - Africa 16
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.844
Nazione #
US - Stati Uniti d'America 3.095
CN - Cina 546
IT - Italia 512
IE - Irlanda 205
SE - Svezia 167
DE - Germania 155
UA - Ucraina 122
FI - Finlandia 117
FR - Francia 110
KR - Corea 88
GB - Regno Unito 78
VN - Vietnam 73
JP - Giappone 68
PL - Polonia 64
CA - Canada 53
BE - Belgio 40
IN - India 36
BR - Brasile 24
IR - Iran 20
AT - Austria 18
TW - Taiwan 18
NL - Olanda 17
HK - Hong Kong 15
NO - Norvegia 14
TR - Turchia 13
AU - Australia 11
ES - Italia 11
SG - Singapore 11
BG - Bulgaria 10
MY - Malesia 10
BY - Bielorussia 8
CL - Cile 8
PT - Portogallo 8
TH - Thailandia 8
MX - Messico 7
SN - Senegal 7
BD - Bangladesh 6
IL - Israele 6
PH - Filippine 6
CO - Colombia 5
CZ - Repubblica Ceca 5
RU - Federazione Russa 5
UZ - Uzbekistan 4
ZA - Sudafrica 4
DK - Danimarca 3
HU - Ungheria 3
RO - Romania 3
SI - Slovenia 3
CH - Svizzera 2
EU - Europa 2
ID - Indonesia 2
IS - Islanda 2
LT - Lituania 2
NG - Nigeria 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
EG - Egitto 1
GR - Grecia 1
KE - Kenya 1
LV - Lettonia 1
MK - Macedonia 1
MQ - Martinica 1
PA - Panama 1
SC - Seychelles 1
UY - Uruguay 1
Totale 5.844
Città #
Chandler 389
Beijing 327
Fairfield 303
Ashburn 202
Dublin 201
Torino 178
Houston 169
Woodbridge 155
Ann Arbor 139
Wilmington 132
Seattle 130
Cambridge 101
Jacksonville 95
Villeurbanne 73
Medford 71
Nyköping 65
Pisa 62
Princeton 60
Dearborn 57
Warsaw 56
Dong Ket 51
Milan 43
Brussels 34
Fremont 34
Redwood City 33
Ottawa 30
Shanghai 28
Guangzhou 27
Turin 25
Boston 22
San Diego 18
San Mateo 17
Taipei 14
Vienna 14
Zhengzhou 13
Boardman 12
Nanjing 12
Stavanger 12
Toronto 12
New York 11
Düsseldorf 10
Norwalk 9
Phoenix 9
Xian 9
London 8
Wuhan 8
Hangzhou 7
Buffalo 6
Chicago 6
Detroit 6
Dhaka 6
Hefei 6
Kuala Lumpur 6
Padova 6
Pavia 6
Santiago 6
Shinjuku 6
Silver Spring 6
Washington 6
Genova 5
Grafing 5
Groningen 5
Jinan 5
Kunming 5
Malo 5
Philadelphia 5
Pozzolo Formigaro 5
Rome 5
San Antonio 5
Tokyo 5
Verona 5
Central 4
Curitiba 4
Delft 4
Galway 4
Heidelberg 4
Helsinki 4
Istanbul 4
Kagoshima 4
Montréal 4
Mumbai 4
Paris 4
Prague 4
Seoul 4
Shenyang 4
Tianjin 4
Auburn Hills 3
Bangkok 3
Bologna 3
Brasília 3
Central District 3
Changchun 3
Changsha 3
Cincinnati 3
Collegeville 3
East Orange 3
Falls Church 3
Fuzhou 3
Gaoping 3
Hanoi 3
Totale 3.721
Nome #
Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application 541
Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. 330
Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis. 307
Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions. 245
Dissection of the biphasic nature of hypoxia-induced motogenic action in bone marrow-derived human mesenchymal stem cells. 176
High energy shock waves enhance the cytotoxic effect of doxorubicin and methotrexate to human osteosarcoma cell lines 172
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas. 165
Mesenchymal stem cells in Amyotrophic Lateral Sclerosis 157
Stem cell therapy applications in amyotrophic lateral sclerosis 137
Myogenic potential of whole bone marrow mesenchymal stem cells in vitro and in vivo for usage in urinary incontinence. 136
Validation of analytical methods in compliance with good manufacturing practice: A practical approach 135
Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity 128
Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients. 120
Stem cell treatment in Amyotrophic Lateral Sclerosis. 119
null 116
Multipotent Mesenchymal Stromal Stem Cell Expansion by Plating Whole Bone Marrow at a Low Cellular Density: A More Advantageous Method for Clinical Use 115
COMPARING THE IMMUNOREGULATORY EFFECTS OF MESENCHYMAL STEM CELLS ISOALTED FROM BONE MARROW, PLACENTA AND AMNIOTIC FLUID 111
Intrahepatic Administration of Human Liver Stem Cells in Infants with Inherited Neonatal-Onset Hyperammonemia: A Phase I Study 111
Analysis of Mesenchymal Stromal Cell Engraftment After Allogeneic HSCT in Pediatric Patients: A Large Multicenter Study 100
Intrabone cord blood hematopoietic stem cell transplantation in a subset of very high-risk pediatric patients: a safety and feasibility pilot study. 96
Inactivated GMP-compliant human platelet lysate for clinical-scale expansion of mesenchymal stem cells. 90
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors 90
The activity of STI571 in human osteosarcoma cells. 89
Mesenchymal stem cell chimerism following HSCT 89
Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. 87
Expansion of mesenchymal stem cells isolated from paediatric and adult donor bone marrow 86
Adult Stem cells and neurodegenerative diseases 85
Ex vivo-expanded bone marrow CD34(+) for acute myocardial infarction treatment: in vitro and in vivo studies. 82
Association between elevated prolactin levels and circulating erythroid precursors in dialyzed patients 79
High-dose thiotepa and etoposide in children with poor-prognosis brain tumors 78
PDGF-BB is an effective mitogenic and chemotactic stimulus for bone marrow – derived human mesenchymal stem cells, putative precursors of profibrogenic myofibroblast – like cells 78
Inactivated human platelet lysate is a new method to censure safer GMP-compliant MSC production. 77
PDGF-BB as mitogenic and chemotactic stimulus for bone marrow – derived human mesenchymal stem cells, putative precursors of profibrogenic myofibroblast – like cells 77
[The c-kit/Stem Cell Factor in the cancerogenetic process of colon-rectal carcinoma. Biological and clinical aspects] 74
Engraftment of bone marrow – derived human mesenchymal stem cells in normal and injured liver of NOD/SCID mice 74
Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: Engraftment and hepatocyte differentiation versus profibrogenic potential 73
Mesenchymal stem cells isolated from amniotic fluid differentiate in neuronal cells 70
Stem cell transplantation in amyotrophic lateral sclerosis patients 70
null 67
Effect of in vitro exposure of corticosteroid drugs, conventionally used in AMD treatment, on mesenchymal stem cells 66
Stem cell transplantation as consolidation therapy for children in first-remission AML: a single-center report. 65
null 64
Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions 61
Mesenchymal stem cells isolated from amniotic fluid differentiate in neural cells 58
Mesenchymal Stem Cell Manufacturing for Clinical Use 58
Neural differentiation of human mesenchymal stem cells: Evidence for expression of neural markers and eag K+ channel types 56
Amyotrophic lateral sclerosis:What goals for cell therapy? 55
Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. 54
STEM CELL TRANSPLANTATION IN AMYOTROPHIC LATERAL SCLEROSIS PATIENTS 46
Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy 45
Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis 44
null 44
Differential expression of transforming growth factors-beta1, -beta2 and -beta3in human colon carcinoma. 42
Stem cells in amyotrophic lateral sclerosis: state of the art 37
The pro-apoptotic factors Fas Ligand and Trail. Molecular mechanisms, physiopathological role and therapeutic potential. 34
A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions 30
Validation of analytical methods in GMP: The disposable Fast Read 102® device, an alternative practical approach for cell counting 27
A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions Preserves the Chemical Characteristics and Biological Activity of Lyo‐Secretome Isolated by Ultrafiltration 26
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriers 25
Mesenchymal stem cells for ALS patients 25
Mesenchymal stem cells isolated from amniotic fluid differentiate in neuronal cells 22
GMP compliant isolation and expansion of MSCs with inactivated human platelet lysate 21
Mesenchymal stem/stromal cell extracellular vesicles: From active principle to next generation drug delivery system 19
State of the Art and New Trends from the 2022 Gism Annual Meeting 12
Generation and characterization of two primary cultures of osteosarcoma and Ewing’s sarcoma 10
Preclinical models of tumour-specific cytotoxic T lymphocytes in sarcoma patients 9
A New Paclitaxel Formulation Based on Secretome Isolated from Mesenchymal Stem Cells Shows a Significant Cytotoxic Effect on Osteosarcoma Cell Lines 4
Totale 6.091
Categoria #
all - tutte 13.923
article - articoli 0
book - libri 0
conference - conferenze 3.077
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.000


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019385 0 0 0 0 0 0 0 69 35 48 164 69
2019/2020955 61 75 64 104 48 114 100 58 73 133 69 56
2020/20211.005 78 196 86 34 94 64 49 69 54 70 69 142
2021/2022785 42 35 27 65 29 47 49 63 35 73 167 153
2022/20231.083 99 81 23 109 100 278 84 56 130 30 55 38
2023/2024434 59 101 36 43 57 69 29 40 0 0 0 0
Totale 6.091